Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Hypothermia on admission to the intensive care unit (ICU) following cardiopulmonary bypass (CPB) is common. The investigators propose that rewarming hypothermic (≤ 35 C) patients admitted to the intensive care unit following procedures using CPB with heated humidified breathing circuits (HHBC) in addition to conventional forced air warming blankets will shorten time to normothermia. Secondarily it may shorten time to extubation, improve coagulopathy, and metabolic derangements seen with hypothermia.
Hypothermia on admission to the intensive care unit (ICU) following cardiopulmonary bypass (CPB) is common. Cooling and rewarming during CPB and deep hypothermic circulatory arrest (DHCA) takes considerable time and contributes to the post-procedural coagulopathy and physiologic perturbations. Core body parts (trunk and head) rewarm more quickly than peripheral parts (extremities). After disconnecting from CPB the body is allowed to self equilibrate. The normal vasoconstriction response is impaired by the administered anaesthesia. Hence, heat distribution takes place from the warm core to the colder periphery. This causes an afterdrop: a decrease in the temperature of the core organs. After-drop may contribute to post-operative complications such as shivering, coagulopathy, increased myocardial stress, increased wound infections, metabolic acidosis, delayed extubation and prolonged ICU length of stay (LOS).
The use of the active warming via traditional methods (ie forced air warming blankets) and Heated Humidified breathing circuits (HHBC) via ANAPOD Heated Humidification System® (ANAPOD) may shorten time to normothermia. Secondarily it may shorten time to extubation, improve coagulopathy, and metabolic derangements seen with hypothermia.
Sample and Study Design- The investigators will prospectively collect data for 14 enrolled non-patients who will receive active warming via both forced air warming blankets and Heated Humidified breathing circuits (HHBC). Retrospective data will be obtained retrospectively for 28 matched patients from two years prior to initiation of the trial, who received warming only via forced air warming blankets.
Data Collection Plan- Data will be extracted and collected by the Duke Department of Anesthesiology IT analyst, who will review and extract information from the patient's chart via Epic/ Maestro Care, or manually if necessary.
Data Evaluation- Descriptive statistics will be used to evaluate patient demographics and clinical characteristics. Descriptive statistics will be summarized as mean ± (SD) or median (interquartile range) for continuous variables and group frequencies (%) for dichotomous or categorical variables.
As all patients are expected to achieve normothermia within the study period, the primary outcome of time to normothermia will be analyzed as a numeric outcome variable. Following validation of distributional assumptions the investigators will compare the time to normothermia between the two groups via t-test or Wilcoxon rank sum test as appropriate. It is expected that the patients will reach normothermia between 45 minutes and 6 hours after admission to the ICU.
By using a 2:1 matching ratio and a moderate level of variability (SD=1.3 hours) a study of 14 prospectively enrolled patients and 28 retrospectively matched patients would attain 82% power to detect a 1.25 hour difference between time to normothermia in the prospective group (active warming via traditional methods (ie forced air warming blankets) and Heated Humidified breathing circuits (HHBC) via ANAPOD Heated Humidification System® (ANAPOD), and the retrospective group (active warming via traditional methods (ie forced air warming blankets only) at alpha level 0.05.
Secondary numeric outcomes such as time to extubation, time to normal PH, and coagulopathy lab values will be analyzed by t-test or Wilcoxon rank sum test as appropriate. Differences in categorical outcomes between treatment groups will be analyzed via chi-square or fisher exact tests. As the patients will be matched on key confounders no further adjustment is expected to be necessary, so the moderate sample size should not limit the primary analysis. Potential subgroup analysis may be conducted in an exploratory analysis to determine if the treatment effect of ANAPOD warming is different by procedure type or patient/surgical characteristics.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HHBC and Forced Air Warming | Experimental | Patients admitted to intensive care unit hypothermic (≤ 35 C) following surgical procedures involving cardiopulmonary bypass. Will be rewarmed with heated humidified breathing circuits (ANAPOD) and standard forced air warming blankets. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Heated Humidified Breathing Circuit and Forced Air Blanket | Device | Heated humidified breathing circuits (ANAPOD) will be set up and managed by respiratory therapist in standard fashion defined by the manufacturer. Temperate will be set at 41C. Forced air warming blankets will be set at 42C for duration of rewarming. |
| Measure | Description | Time Frame |
|---|---|---|
| Time to Normothermia | Core temperature normothermia defined as >=36.5 C. | up to 24 hours post admission to intensive care unit |
| Measure | Description | Time Frame |
|---|---|---|
| Time to Extubation | Time from admission to time of extubation. Followup was truncated at 24 hours and if patient had not been extubated at that time they were assigned a value of 24 hours. | up to 24 hours post admission to intensive care unit |
| Coagulopathy as Measured by Need for Transfusion of Blood Product |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Negmeldeen Mamoun, MD | Duke Univeristy Hospital Anesthesia Department | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Duke University Hospital | Durham | North Carolina | 27710 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | HHBC and Forced Air Warming | Patients admitted to intensive care unit hypothermic (≤ 35 C) following surgical procedures involving cardiopulmonary bypass. Will be rewarmed with heated humidified breathing circuits (ANAPOD) and standard forced air warming blankets. Heated Humidified Breathing Circuit and Forced Air Blanket: Heated humidified breathing circuits (ANAPOD) will be set up and managed by respiratory therapist in standard fashion defined by the manufacturer. Temperate will be set at 41C. Forced air warming blankets will be set at 42C for duration of rewarming. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | HHBC and Forced Air Warming | Patients admitted to intensive care unit hypothermic (≤ 35 C) following surgical procedures involving cardiopulmonary bypass. Will be rewarmed with heated humidified breathing circuits (ANAPOD) and standard forced air warming blankets. Heated Humidified Breathing Circuit and Forced Air Blanket: Heated humidified breathing circuits (ANAPOD) will be set up and managed by respiratory therapist in standard fashion defined by the manufacturer. Temperate will be set at 41C. Forced air warming blankets will be set at 42C for duration of rewarming. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Time to Normothermia | Core temperature normothermia defined as >=36.5 C. | Posted | Median | Inter-Quartile Range | hours | up to 24 hours post admission to intensive care unit |
|
From ICU admission to hospital discharge (ranged between 5 and 9 days)
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | HHBC and Forced Air Warming | Patients admitted to intensive care unit hypothermic (≤ 35 C) following surgical procedures involving cardiopulmonary bypass. Will be rewarmed with heated humidified breathing circuits (ANAPOD) and standard forced air warming blankets. Heated Humidified Breathing Circuit and Forced Air Blanket: Heated humidified breathing circuits (ANAPOD) will be set up and managed by respiratory therapist in standard fashion defined by the manufacturer. Temperate will be set at 41C. Forced air warming blankets will be set at 42C for duration of rewarming. |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Complete Heart Block | Cardiac disorders | Non-systematic Assessment |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Atrial Fibrillation | Cardiac disorders | Non-systematic Assessment |
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Negmeldeen Mamoun, M.D. | Duke University | 919-681-3551 | negmeldeen.mamoun@duke.edu |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Feb 25, 2019 | Jun 11, 2020 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D007035 | Hypothermia |
| ID | Term |
|---|---|
| D001832 | Body Temperature Changes |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
The intervention group has only one arm. All patients will use active warming via traditional methods (ie forced air warming blankets) and Heated Humidified breathing circuits (HHBC) via ANAPOD Heated Humidification System® (ANAPOD). Those patients will be matched with a retrospective historical cohort of patients that received active warming via traditional methods only (forced air warming blankets).
Not provided
Not provided
Not provided
Not provided
|
|
Assessed via number of transfusions of red blood cells, fresh frozen plasma, platelets, cryoprecipitate. |
| 24 hours post admission to intensive care unit |
| Metabolic Derangement as Measured by Time to Normal pH | Assessed via blood gas analysis. Normal pH defined as 7.35-7.45. | up to 24 hours post admission to intensive care unit |
| Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Prothrombin Time | Laboratory assessment of Prothrombin Time with normal defined as 9.5-13.1 seconds. | 24 hours post admission to intensive care unit |
| Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of INR | Laboratory assessment of international normalised ratio (INR) with normal defined as 0.9-1.1. | 24 hours post admission to intensive care unit |
| Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Act Partial Thromboplastin Time | Laboratory assessment of Act Partial Thromboplastin Time with normal defined as 26.8-37.1 seconds. | 24 hours post admission to intensive care unit |
| Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Fibrinogen. | Laboratory assessment of fibrinogen levels with normal defined as 213-435 mg/dL. | 24 hours post admission to intensive care unit |
| Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Platelet Count | Laboratory assessment of platelet count with normal defined as 150 - 450 x10ˆ9/L. | 24 hours post admission to intensive care unit |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| Region of Enrollment | Count of Participants | Participants |
|
| Temperature at ICU admission | Median | Inter-Quartile Range | Degrees Celsius |
|
| Units | Counts |
|---|
| Participants |
|
|
| Secondary | Time to Extubation | Time from admission to time of extubation. Followup was truncated at 24 hours and if patient had not been extubated at that time they were assigned a value of 24 hours. | Posted | Median | Inter-Quartile Range | hours | up to 24 hours post admission to intensive care unit |
|
|
|
| Secondary | Coagulopathy as Measured by Need for Transfusion of Blood Product | Assessed via number of transfusions of red blood cells, fresh frozen plasma, platelets, cryoprecipitate. | Posted | Median | Full Range | Units transfused | 24 hours post admission to intensive care unit |
|
|
|
| Secondary | Metabolic Derangement as Measured by Time to Normal pH | Assessed via blood gas analysis. Normal pH defined as 7.35-7.45. | Posted | Median | Inter-Quartile Range | hours | up to 24 hours post admission to intensive care unit |
|
|
|
| Secondary | Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Prothrombin Time | Laboratory assessment of Prothrombin Time with normal defined as 9.5-13.1 seconds. | Posted | Count of Participants | Participants | 24 hours post admission to intensive care unit |
|
|
|
| Secondary | Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of INR | Laboratory assessment of international normalised ratio (INR) with normal defined as 0.9-1.1. | Posted | Count of Participants | Participants | 24 hours post admission to intensive care unit |
|
|
|
| Secondary | Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Act Partial Thromboplastin Time | Laboratory assessment of Act Partial Thromboplastin Time with normal defined as 26.8-37.1 seconds. | Posted | Count of Participants | Participants | 24 hours post admission to intensive care unit |
|
|
|
| Secondary | Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Fibrinogen. | Laboratory assessment of fibrinogen levels with normal defined as 213-435 mg/dL. | Posted | Count of Participants | Participants | 24 hours post admission to intensive care unit |
|
|
|
| Secondary | Number of Subjects With Abnormal Coagulopathy as Measured by Laboratory Assessment of Platelet Count | Laboratory assessment of platelet count with normal defined as 150 - 450 x10ˆ9/L. | Posted | Count of Participants | Participants | 24 hours post admission to intensive care unit |
|
|
|
| 1 |
| 14 |
| 2 |
| 14 |
| 8 |
| 14 |
| Hemorrhagic Stroke | Vascular disorders | Non-systematic Assessment |
|
| Acute Kidney Injury | Renal and urinary disorders | Non-systematic Assessment |
|
| Urinary Tract Infection | Renal and urinary disorders | Non-systematic Assessment |
|
| Complete Heart Block | Cardiac disorders | Non-systematic Assessment |
|
| COPD exacerbation | Respiratory, thoracic and mediastinal disorders | Non-systematic Assessment |
|
Not provided
Not provided
Not provided